1. Home
  2. MAIA vs BTOC Comparison

MAIA vs BTOC Comparison

Compare MAIA & BTOC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MAIA
  • BTOC
  • Stock Information
  • Founded
  • MAIA 2018
  • BTOC 2020
  • Country
  • MAIA United States
  • BTOC United States
  • Employees
  • MAIA N/A
  • BTOC N/A
  • Industry
  • MAIA Biotechnology: Pharmaceutical Preparations
  • BTOC
  • Sector
  • MAIA Health Care
  • BTOC
  • Exchange
  • MAIA Nasdaq
  • BTOC Nasdaq
  • Market Cap
  • MAIA 46.7M
  • BTOC 48.3M
  • IPO Year
  • MAIA 2022
  • BTOC 2024
  • Fundamental
  • Price
  • MAIA $1.95
  • BTOC $1.19
  • Analyst Decision
  • MAIA
  • BTOC
  • Analyst Count
  • MAIA 0
  • BTOC 0
  • Target Price
  • MAIA N/A
  • BTOC N/A
  • AVG Volume (30 Days)
  • MAIA 283.6K
  • BTOC 60.5K
  • Earning Date
  • MAIA 05-09-2025
  • BTOC 05-16-2025
  • Dividend Yield
  • MAIA N/A
  • BTOC N/A
  • EPS Growth
  • MAIA N/A
  • BTOC N/A
  • EPS
  • MAIA N/A
  • BTOC N/A
  • Revenue
  • MAIA N/A
  • BTOC $184,757,071.00
  • Revenue This Year
  • MAIA N/A
  • BTOC $30.78
  • Revenue Next Year
  • MAIA N/A
  • BTOC $17.61
  • P/E Ratio
  • MAIA N/A
  • BTOC N/A
  • Revenue Growth
  • MAIA N/A
  • BTOC 8.83
  • 52 Week Low
  • MAIA $1.40
  • BTOC $0.80
  • 52 Week High
  • MAIA $4.31
  • BTOC $8.74
  • Technical
  • Relative Strength Index (RSI)
  • MAIA 57.09
  • BTOC N/A
  • Support Level
  • MAIA $1.71
  • BTOC N/A
  • Resistance Level
  • MAIA $1.81
  • BTOC N/A
  • Average True Range (ATR)
  • MAIA 0.09
  • BTOC 0.00
  • MACD
  • MAIA 0.00
  • BTOC 0.00
  • Stochastic Oscillator
  • MAIA 70.59
  • BTOC 0.00

About MAIA MAIA Biotechnology Inc.

MAIA Biotechnology Inc is a clinical-stage biopharmaceutical company developing targeted immunotherapies for cancer. THIO (6-thio-dG or 6-thio-2 '-deoxyguanosine), its lead asset, is an investigational dual mechanism of action drug candidate incorporating telomere targeting and immunogenicity. Patients with advanced NSCLC will be treated first with THIO followed a few days later by the immune checkpoint inhibitor Libtayo (cemiplimab), manufactured and commercialized by Regeneron.

About BTOC Armlogi Holding Corp. Common Stock

Armlogi Holding Corp is a fast-growing U.S.-based warehousing and logistics service provider that offers a comprehensive package of supply-chain solutions relating to warehouse management and order fulfillment. The company provides one-stop warehousing and logistics services to cross-border e-commerce merchants outside the U.S. who seek to sell in the U.S. market. The warehouses are equipped with automated sorting systems, heavy-duty forklifts, and pallets and trays that are suitable for processing bulky items. The services of the company include customs brokerage services, transportation of merchandise to U.S. warehouses, and warehouse management and order fulfillment services.

Share on Social Networks: